Osteoarthritis drug Prexige under review by Health Canada
Thursday, August 16, 2007 | 12:52 PM ET
Health Canada is reviewing the safety of the anti-inflammatory Prexige (lumiracoxib) following reports of serious liver adverse events in some patients in Australia.
Prexige, made by Novartis Pharmaceuticals Canada Inc., is a Cox-2 inhibitor, non-steroidal drug used to treat adult osteoarthritis.
Australia's federal regulatory authority, the Therapeutic Goods Administration, recently withdrew market authorization for Prexige due to eight reports of serious liver adverse events linked to the drug.
These included including two deaths and two liver transplants in Australia, primarily involving use of 200-mg and 400-mg doses daily.
In Canada, Prexige was authorized for sale in November 2006 for acute and chronic treatment of the signs and symptoms of knee osteoarthritis in adults, and in July 2007 for general osteoarthritis in adults.
The current label indicates the drug should not be used in patients with severe liver impairment or active liver disease.
The Canadian maximum daily dose recommended is 100 mg; in Australia, the maximum daily dose recommended ranged from 100 mg to 400 mg daily.
Once Health Canada has reviewed the available data, new information, including any resulting recommendations, will be made public to Canadians and health-care professionals.
Health Canada advises patients that Prexige should be limited to the lowest effective dose for the shortest possible duration of treatment.
They should consult with their doctors before making any change to their medication, or if they have any questions or concerns.
Recalls and Advisories »
Recent Topics
- Diving equipment recalled
- Friday, October 2, 2009
- Wet n’ Wild eye makeup remover recalled over contamination
- Friday, September 25, 2009
- Thermostat with built-in GFCI recalled over electric shock risk
- Friday, September 25, 2009
- Magzoid magnetic construction toys recalled
- Friday, September 25, 2009
- Big Lots Stores, Inc. recalls bunk beds over collapse and fall danger
- Wednesday, September 23, 2009
- Subscribe to Recalls and Advisories
Categories
- Health & Food (386)
- Cars & Vehicles (74)
- Children's Products (484)
- Home & Recreation (488)
Archives
- October 2009 (1)
- September 2009 (21)
- August 2009 (39)
- July 2009 (51)
- June 2009 (48)
- May 2009 (37)
- April 2009 (54)
- March 2009 (73)
- February 2009 (56)
- January 2009 (53)
- December 2008 (25)
- November 2008 (17)
- October 2008 (53)
- September 2008 (52)
- August 2008 (52)
- July 2008 (46)
- June 2008 (32)
- May 2008 (35)
- April 2008 (31)
- March 2008 (31)
- February 2008 (26)
- January 2008 (36)
- December 2007 (43)
- November 2007 (45)
- October 2007 (45)
- September 2007 (22)
- August 2007 (39)
- July 2007 (42)
- June 2007 (39)
- May 2007 (29)
- April 2007 (23)
- March 2007 (42)
- February 2007 (36)
- January 2007 (30)
- December 2006 (46)
- November 2006 (39)
- October 2006 (33)
- September 2006 (41)
- August 2006 (37)